FdaApplication
NDA 217379
Identifiers
- fda_app_no: NDA217379
Properties
| Property | Value |
|---|---|
| applicant_name | CYCLE PHARMACEUTICALS LTD |
| application_type | NDA |
| approval_date | 2026-05-29 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CAVHANZA | NILOTINIB | 80MG | TABLET, ORALLY DISINTEGRATING;ORAL |
| CAVHANZA | NILOTINIB | 60MG | TABLET, ORALLY DISINTEGRATING;ORAL |
2 products